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Upon reviewing the article, the authors noticed an error in Figure 5D on page 10019, it should be presented as follows:

The authors confirm that all of the results and conclusions of the article remain unchanged. The authors apologize for this error.Figure 5LINC00565 regulates the tumor growth in vivo. (**A**) The growth of tumors from sh-LINC00565 group were markedly slower than these from sh-NC group. (**B**) The tumors dissected from sh-LINC00565 group node mice were lighter than the sh-NC group. (**C**) qRT-PCR verified that LINC00565 expression was lower in sh-LINC00565 group than that in sh-NC group. (**D**) Immunohistochemistry showed that PCNA, Ki-67, Cyclin D1, Cyclin E1 and CDK4 were markedly reduced in LINC00565 knockdown group compared with NC group, nevertheless, P16 and P21 showed the opposite effect. ^\*\*\*^P \< 0.001.
